Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-19

Clinical Trial Update: Elimination of Incretin Hormones in Patients With Severe Kidney Failure

View source ↗

Summary

This completed clinical study investigated the elimination of incretin hormones in patients with severe kidney failure (uremia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bo Feldt-Rasmussen | Conditions: Uremia | Status: COMPLETED